These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 33833407)
1. Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis. Wang F; Wang JN; He XY; Suo XG; Li C; Ni WJ; Cai YT; He Y; Fang XY; Dong YH; Xing T; Yang YR; Zhang F; Zhong X; Zang HM; Liu MM; Li J; Meng XM; Jin J Acta Pharmacol Sin; 2022 Feb; 43(2):330-341. PubMed ID: 33833407 [TBL] [Abstract][Full Text] [Related]
2. RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation. Xu CH; Wang JN; Suo XG; Ji ML; He XY; Chen X; Zhu S; He Y; Xie SS; Li C; Dong ZH; Chen Y; Ni WJ; Feng XW; Liu MM; Jin J; Li Z; Meng XM Int Immunopharmacol; 2022 Nov; 112():109262. PubMed ID: 36166972 [TBL] [Abstract][Full Text] [Related]
3. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation. Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782 [TBL] [Abstract][Full Text] [Related]
4. Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation. Yang Q; Ren GL; Wei B; Jin J; Huang XR; Shao W; Li J; Meng XM; Lan HY Theranostics; 2019; 9(26):8277-8293. PubMed ID: 31754396 [No Abstract] [Full Text] [Related]
5. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress. Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969 [TBL] [Abstract][Full Text] [Related]
6. Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis. He XY; Wang F; Suo XG; Gu MZ; Wang JN; Xu CH; Dong YH; He Y; Zhang Y; Ji ML; Chen Y; Zhang MM; Fan YG; Wen JG; Jin J; Wang J; Li J; Zhuang CL; Liu MM; Meng XM Br J Pharmacol; 2023 Oct; 180(20):2641-2660. PubMed ID: 37248964 [TBL] [Abstract][Full Text] [Related]
7. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation. Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190 [TBL] [Abstract][Full Text] [Related]
8. A Role for Tubular Necroptosis in Cisplatin-Induced AKI. Xu Y; Ma H; Shao J; Wu J; Zhou L; Zhang Z; Wang Y; Huang Z; Ren J; Liu S; Chen X; Han J J Am Soc Nephrol; 2015 Nov; 26(11):2647-58. PubMed ID: 25788533 [TBL] [Abstract][Full Text] [Related]
9. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases. Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850 [TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395 [TBL] [Abstract][Full Text] [Related]
11. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis. Meng XM; Li HD; Wu WF; Ming-Kuen Tang P; Ren GL; Gao L; Li XF; Yang Y; Xu T; Ma TT; Li Z; Huang C; Zhang L; Lv XW; Li J Lab Invest; 2018 Jan; 98(1):79-94. PubMed ID: 29200200 [TBL] [Abstract][Full Text] [Related]
12. Gentamicin-Induced Acute Kidney Injury in an Animal Model Involves Programmed Necrosis of the Collecting Duct. Huang H; Jin WW; Huang M; Ji H; Capen DE; Xia Y; Yuan J; Păunescu TG; Lu HAJ J Am Soc Nephrol; 2020 Sep; 31(9):2097-2115. PubMed ID: 32641397 [TBL] [Abstract][Full Text] [Related]
13. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD. Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627 [TBL] [Abstract][Full Text] [Related]
14. RIPK3 mediates renal tubular epithelial cell apoptosis in endotoxin‑induced acute kidney injury. Zhang S; Li R; Dong W; Yang H; Zhang L; Chen Y; Wang W; Li C; Wu Y; Ye Z; Zhao X; Li Z; Zhang M; Liu S; Liang X Mol Med Rep; 2019 Aug; 20(2):1613-1620. PubMed ID: 31257491 [TBL] [Abstract][Full Text] [Related]
15. Bone Marrow-Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury. Martin-Sanchez D; Guerrero-Mauvecin J; Fontecha-Barriuso M; Mendez-Barbero N; Saiz ML; Lopez-Diaz AM; Sanchez-Niño MD; Carrasco S; Cannata-Ortiz P; Ruiz-Ortega M; Ortiz A; Sanz AB J Am Soc Nephrol; 2022 Feb; 33(2):357-373. PubMed ID: 35046131 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a chalcone derivative as potent necroptosis inhibitor for the treatment of acute kidney injury. Li C; Chen QY; He Y; Liu YH; Meng XM; Liu MM Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):824-835. PubMed ID: 35579574 [TBL] [Abstract][Full Text] [Related]
18. Necroptosis in 3-chloro-1, 2-propanediol (3-MCPD)-dipalmitate-induced acute kidney injury in vivo and its repression by miR-223-3p. Huang G; Xue J; Sun X; Wang J; Yu LL Toxicology; 2018 Aug; 406-407():33-43. PubMed ID: 29860048 [TBL] [Abstract][Full Text] [Related]
19. Artesunate relieves acute kidney injury through inhibiting macrophagic Mincle-mediated necroptosis and inflammation to tubular epithelial cell. Lei XY; Tan RZ; Jia J; Wu SL; Wen CL; Lin X; Wang H; Shi ZJ; Li B; Kang Y; Wang L J Cell Mol Med; 2021 Sep; 25(18):8775-8788. PubMed ID: 34337860 [TBL] [Abstract][Full Text] [Related]
20. Cadmium (Cd) and 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) co-exposure induces acute kidney injury through oxidative stress and RIPK3-dependent necroptosis. Tang J; Zhang N; Chen S; Hu K; Li Y; Fang Y; Wu Z; Zhang Y; Xu L Environ Toxicol; 2023 Oct; 38(10):2332-2343. PubMed ID: 37357614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]